Nothing Special   »   [go: up one dir, main page]

ATE397000T1 - Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs - Google Patents

Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs

Info

Publication number
ATE397000T1
ATE397000T1 AT05750033T AT05750033T ATE397000T1 AT E397000 T1 ATE397000 T1 AT E397000T1 AT 05750033 T AT05750033 T AT 05750033T AT 05750033 T AT05750033 T AT 05750033T AT E397000 T1 ATE397000 T1 AT E397000T1
Authority
AT
Austria
Prior art keywords
tetrahydropyridothiophenes
cancer
treatment
compounds
proliferative
Prior art date
Application number
AT05750033T
Other languages
English (en)
Inventor
Klaus Pekari
Thomas Baer
Mathias Schmidt
Thomas Beckers
Bjoern Bartels
Petra Gimmnich
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE397000T1 publication Critical patent/ATE397000T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT05750033T 2004-06-04 2005-06-03 Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs ATE397000T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04102531 2004-06-04

Publications (1)

Publication Number Publication Date
ATE397000T1 true ATE397000T1 (de) 2008-06-15

Family

ID=34929170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05750033T ATE397000T1 (de) 2004-06-04 2005-06-03 Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs

Country Status (9)

Country Link
US (2) US7517986B2 (de)
EP (1) EP1756118B1 (de)
JP (1) JP2008501668A (de)
AT (1) ATE397000T1 (de)
AU (1) AU2005250184B2 (de)
CA (1) CA2568718A1 (de)
DE (1) DE602005007220D1 (de)
ES (1) ES2308504T3 (de)
WO (1) WO2005118592A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
CN1988934B (zh) * 2004-05-28 2011-01-05 奥坦纳医药公司 四氢吡啶并噻吩化合物
CA2568718A1 (en) * 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
AU2005251485A1 (en) 2004-06-11 2005-12-22 4Sc Ag Tetrahydropyridothiophenes for treating hyperproliferative disorders
JP2008529989A (ja) * 2005-02-09 2008-08-07 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌のような増殖性の疾病の治療用のテトラヒドロピリドチオフェン
CA2609003A1 (en) * 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
WO2006125815A2 (en) * 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
JP2010500395A (ja) * 2006-08-16 2010-01-07 ４エスツェー アクチェンゲゼルシャフト 癌治療のためのテトラヒドロピリドチオフェン誘導体
CN102188698B (zh) * 2010-03-08 2014-10-01 上海南方模式生物科技发展有限公司 核糖核酸酶和青蒿素的联用
KR101633453B1 (ko) * 2015-06-17 2016-06-24 한국과학기술연구원 대사성 글루타메이트 수용체 1, 5에 활성을 보이는 신규 테트라하이드로티에노[2,3-ｃ]피리딘 유도체
CN108558848A (zh) * 2018-04-19 2018-09-21 华东师范大学 一种环烷烃并噻吩衍生物及其制备方法和医药用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1225167B (de) * 1965-04-07 1966-09-22 Huels Chemische Werke Ag Verfahren zur Herstellung aliphatischer, aromatischer oder gemischt aliphatisch-aromatischer Sulfone
JPS5498337A (en) * 1978-01-06 1979-08-03 Dai Ichi Seiyaku Co Ltd Anticarcinogenic and/or antimetastatic agent
DD272078A1 (de) 1986-04-15 1989-09-27 Dresden Arzneimittel Verfahren zur herstellung von 6-substituierten 2-acylamio-4,5,6,7-tetrahydro-thieno[2,3-c]-pyridin-3-carbonsaeure-derivaten
DE4039734A1 (de) 1990-12-13 1992-06-17 Basf Ag Substituierte 2-aminothiophene enthaltende herbizide mittel
JP3074640B2 (ja) * 1995-12-22 2000-08-07 インターナショナル・ビジネス・マシーンズ・コーポレ−ション 液晶表示装置の駆動方法
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JP2002506072A (ja) * 1998-03-12 2002-02-26 ノボ ノルディスク アクティーゼルスカブ プロテインチロシンホスファターゼ（ＰＴＰａｓｅ）のモジュレーター
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
WO2002092076A1 (en) * 2001-05-16 2002-11-21 Cytovia, Inc. Substituted coumarins and quinolines as caspases activators
US20040171603A1 (en) * 2001-05-18 2004-09-02 Janos Pato Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
US20030232994A1 (en) * 2001-10-04 2003-12-18 Shao-Po Lu Bicyclic thiophene derivatives and combinatorial libraries thereof
JP4103425B2 (ja) * 2002-03-28 2008-06-18 セイコーエプソン株式会社 電気光学装置、電子機器及び投射型表示装置
ATE421519T1 (de) 2002-09-12 2009-02-15 Merck & Co Inc Substituierte bizyklische thiophen-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
EP1538903A2 (de) 2002-09-12 2005-06-15 Merck & Co., Inc. Verfahren zur behandlung von diabetes und damit einhergehenden erkrankungen
IL154306A0 (en) 2003-02-05 2003-09-17 Rimonyx Pharmaceuticals Ltd Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
GB0324653D0 (en) 2003-10-22 2003-11-26 Syngenta Participations Ag Fungicides
WO2005060711A2 (en) 2003-12-19 2005-07-07 Elixir Pharmaceuticals, Inc. Methods of treating a disorder
US7745630B2 (en) * 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
CN1988934B (zh) 2004-05-28 2011-01-05 奥坦纳医药公司 四氢吡啶并噻吩化合物
CA2568718A1 (en) * 2004-06-04 2005-12-15 Altana Pharma Ag Tetrahydropyridothiophenes for use in the treatment of cancer
AU2005251485A1 (en) 2004-06-11 2005-12-22 4Sc Ag Tetrahydropyridothiophenes for treating hyperproliferative disorders

Also Published As

Publication number Publication date
US20090163538A1 (en) 2009-06-25
WO2005118592A8 (en) 2006-10-12
ES2308504T3 (es) 2008-12-01
US20070213360A1 (en) 2007-09-13
EP1756118A1 (de) 2007-02-28
EP1756118B1 (de) 2008-05-28
AU2005250184B2 (en) 2011-04-21
AU2005250184A1 (en) 2005-12-15
WO2005118592A1 (en) 2005-12-15
DE602005007220D1 (de) 2008-07-10
US7517986B2 (en) 2009-04-14
CA2568718A1 (en) 2005-12-15
JP2008501668A (ja) 2008-01-24

Similar Documents

Publication Publication Date Title
CY1108399T1 (el) Τετραϋδροπυριδοθειοφαινια
DE602004024909D1 (de) Platinkomplexe zur behandlung von tumoren
DE602006014843D1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
ATE517896T1 (de) P38-kinase-inhibitoren
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
NO20071127L (no) Triazoloftalaziner
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
WO2006125813A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
WO2006125815A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
DE602006016333D1 (de) Azaxanthonen zur behandlung von tumoren
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602005024572D1 (de) Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
DE502005007105D1 (de) 4-amino-5-oxo-8-phenyl-5h-pyrido-ä2,3-dü-pyrimidin-derivate als inhibitoren der tyrosinkinasen und der raf-kinasen zur behandlung von tumoren
DE602006018725D1 (de) Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom
DE602005027251D1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
DE602005019770D1 (de) Medizinische zusammensetzung zur behandlung von krebs oder diabetes
ATE532513T1 (de) Verwendung von 4-cyclopropylmethoxy-n-(3,5- dichlor-1-oxidopyridin-4-yl)-5-(methoxy)-pyridi - 2-carboxamid zur behandlung von schädeltraumata
ATE521351T1 (de) Verwendung von 7-t-butoxyiminomethylcamptothecin zur behandlung von gebärmuttertumoren
AR051035A1 (es) Uso de epotilonas en el tratamiento de metastasis en hueso
DE502006009303D1 (de) Acylglycerophospholipide zur behandlung von krebs-begleiterscheinungen
TH77920A (th) การใช้อิโพธิโลนในการรักษาการย้ายที่ของโรคมาที่กระดูก

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties